Search Results 1031-1040 of 16878 for melatonin receptor agonists
Small molecule receptor tyrosine kinase inhibitor (TKI) therapy (including investigational) within 2 weeks or 5 half-lives, whichever is longer;; Any type of ...
... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...
The purpose of this study is to determine if lung ultrasound surface wave elastography (LUSWE) can accurately detect changes in lung elasticity (compliance) ...
Explore services for a healthy lifestyle, early disease detection, preventive strategies and diagnosis of adults with unexplained symptoms.
We will identify innate immune cell populations that contribute to astrocyte reactivity and elucidate the mechanisms responsible for altering the ...
... receptor 2 (HER2) targeted agent. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; Adequate hematologic, hepatic, and renal function ...
Estrogen receptor (ER)/progesterone receptor (PR)-negative (≤ 5% cells) by immunohistochemistry (IHC) and human epidermal grow (HER2) negative (by IHC or ...
Some women report relief from endometriosis pain after acupuncture treatment. However, research is sparse on this — or any other — alternative treatment for ...
... agonist medication or less than 6 half-lives from discontinuance of dopamine agonists); Pregnant; Nursing; Men or women of childbearing potential who are ...
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!